Abstract
Metastatic melanoma is the most aggressive among skin cancers, and current treatments based on the inhibition of BRAF / MEK become ineffective because the adaptive response favors the selection and proliferation of treatment-resistant tumor cells. It is well accepted that cancer cells undergo significant metabolic changes to be able to proliferate even in scarce nutrient environments, an …